Document is current
Any future updates will be listed below
-
Authors
,
Tashiro, Hiroshi
Tanaka, Akihito https://orcid.org/0000-0003-2260-1942
Ishii, Hideki
Takagi, Kensuke
Uemura, Yusuke
Inoue, Yosuke
Umemoto, Norio
Negishi, Yosuke
Shibata, Naoki
Yoshioka, Naoki
Shimizu, Kiyokazu
Morishima, Itsuro
Watarai, Masato
Asano, Hiroshi
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 15 May 2020
Accepted: 23 October 2020
First Online: 5 November 2020
Compliance with ethical standards
:
: Hideki Ishii received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. Yusuke Uemura recieved lecture fees from Otsuka Pharma Ltd. Itsuro Morishima received lecture fees from Daiichi-Sankyo Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Abbott Japan. Toyoaki Murohara received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. Toyoaki Murohara received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
